Cargando…

Development of a Patient-Centred, Psychosocial Support Intervention for Multi-Drug-Resistant Tuberculosis (MDR-TB) Care in Nepal

Multi-drug-resistant tuberculosis (MDR-TB) poses a major threat to public health worldwide, particularly in low-income countries. The current long (20 month) and arduous treatment regime uses powerful drugs with side-effects that include mental ill-health. It has a high loss-to-follow-up (25%) and h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khanal, Sudeepa, Elsey, Helen, King, Rebecca, Baral, Sushil C., Bhatta, Bharat Raj, Newell, James N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242498/ https://www.ncbi.nlm.nih.gov/pubmed/28099475 http://dx.doi.org/10.1371/journal.pone.0167559

Ejemplares similares

Implementation of a psychosocial support package for people receiving treatment for multidrug-resistant tuberculosis in Nepal: A feasibility and acceptability study
por: Walker, Ian F., et al.
Publicado: (2018)

Understanding implementation and feasibility of tobacco cessation in routine primary care in Nepal: a mixed methods study
por: Elsey, Helen, et al.
Publicado: (2016)

Public Health Risks in Urban Slums: Findings of the Qualitative ‘Healthy Kitchens Healthy Cities’ Study in Kathmandu, Nepal
por: Elsey, Helen, et al.
Publicado: (2016)

Using behaviour change theory to train health workers on tobacco cessation support for tuberculosis patients: a mixed-methods study in Bangladesh, Nepal and Pakistan
por: Warsi, Sahil, et al.
Publicado: (2019)

Costs of a successful public-private partnership for TB control in an urban setting in Nepal
por: Karki, Deepak K, et al.
Publicado: (2007)

Community-based DOTS and family member DOTS for TB control in Nepal: costs and cost-effectiveness
por: Mirzoev, Tolib N, et al.
Publicado: (2008)

Causes of stigma and discrimination associated with tuberculosis in Nepal: a qualitative study
por: Baral, Sushil C, et al.
Publicado: (2007)

Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study
por: Ghimire, Samiksha, et al.
Publicado: (2020)

Engaging Female Community Health Volunteers (FCHVs) for cardiovascular diseases risk screening in Nepal
por: Rawal, Lal B., et al.
Publicado: (2022)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
por: Ali, Monadil H., et al.
Publicado: (2019)

‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012)

Collaborative public–private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012–2016
por: Shelby, Peter W, et al.
Publicado: (2017)

The importance of providing counselling and financial support to patients receiving treatment for multi-drug resistant TB: mixed method qualitative and pilot intervention studies
por: Baral, Sushil C, et al.
Publicado: (2014)

Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
por: Mehari, Kibriti, et al.
Publicado: (2019)

Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
por: Kundu, Debashish, et al.
Publicado: (2018)

759. Molecular Characterization and Epidemiology of Multidrug-Resistant Mycobacterium tuberculosis (MDR-TB) and Identification of Possible Cases of Local Transmission of MDR-TB in Kuwait
por: Mokaddas, Eiman, et al.
Publicado: (2018)

MDR TB Transmission, Singapore
por: Chee, Cynthia B.E., et al.
Publicado: (2013)

Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2019)

Drug Susceptibility of Mycobacterium tuberculosis Beijing Genotype and Association with MDR TB
por: de Steenwinkel, Jurriaan E.M., et al.
Publicado: (2012)

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
por: Sabur, Natasha F., et al.
Publicado: (2021)

β-Lactamase-Producing Multidrug-Resistant Bacterial Pathogens from Tracheal Aspirates of Intensive Care Unit Patients at National Institute of Neurological and Allied Sciences, Nepal
por: Khanal, Santosh, et al.
Publicado: (2013)

From Rags to Riches: Assessing poverty and vulnerability in urban Nepal
por: Ensor, Tim, et al.
Publicado: (2020)

Correction to: Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2020)

Adverse Events in Healthy Individuals and MDR-TB Contacts Treated with Anti-Tuberculosis Drugs Potentially Effective for Preventing Development of MDR-TB: A Systematic Review
por: Langendam, Miranda W., et al.
Publicado: (2013)

Risk factors of tuberculosis in human and its association with cattle TB in Nepal: A one health approach
por: Gompo, Tulsi Ram, et al.
Publicado: (2020)

Prevalencia de tuberculosis en contactos de pacientes con TB-MDR : /
por: Ribí García, Alberto
Publicado: (2009)

Molecular Approaches for Detection of the Multi-Drug Resistant Tuberculosis (MDR-TB) in Bangladesh
por: Aurin, Tafsina Haque, et al.
Publicado: (2014)

Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China
por: Pang, Yu, et al.
Publicado: (2016)

Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali()
por: Baya, Bocar, et al.
Publicado: (2019)

Diagnostic Opportunities for Optimizing Management of Multidrug-Resistant Tuberculosis (MDR-TB) in Tanzania
por: Mpagama, Stellah G
Publicado: (2018)

Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar
por: Wai, Pyae Phyo, et al.
Publicado: (2018)

The implementation of Xpert MTB/RIF assay for diagnosis of tuberculosis in Nepal: A mixed-methods analysis
por: Joshi, Basant, et al.
Publicado: (2018)

First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2022)

Morbidity surveillance and treatment of MDR-TB with the support of NGOs in Ukraine
por: Pozharova, Inga, et al.
Publicado: (2018)

Mortality among MDR-TB Cases: Comparison with Drug-Susceptible Tuberculosis and Associated Factors
por: Chung-Delgado, Kocfa, et al.
Publicado: (2015)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

Bedaquiline (BDQ) resistance in an adolescent with multidrug-resistant tuberculosis (MDR-TB): An alarm for pediatricians
por: Cesilia, Citra, et al.
Publicado: (2023)

Management of MDR-TB: Review of Iran's Experience
por: Masjedi, Mohammad Reza, et al.
Publicado: (2013)

MDR-TB in Pakistan: Challenges, efforts, and recommendations
por: Khan, Mahad Ahmed, et al.
Publicado: (2022)

Issues in design and interpretation of MDR-TB clinical trials: report of the first Global MDR-TB Clinical Trials Landscape Meeting
por: Mitnick, Carole D, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n61p91b2kgpi50e28l5kas93il